Nimbus Therapeutics Announces Closing of Takeda's Acquisition of TYK2 Subsidiary

BOSTON--(BUSINESS WIRE)--Nimbus Therapeutics, LLC (“Nimbus Therapeutics” or “Nimbus”), a clinical-stage company that designs and develops breakthrough m

Related Keywords

Boston ,Massachusetts ,United States ,Jeb Keiper ,Nimbus Lakshmi Inc ,Nimbus Therapeutics ,Nimbus Lakshmi ,Chief Executive Officer ,Psoriasis Area ,Severity Index ,